Clinical Trial

Comparative Study for Facial Scar Remodeling Using Fractional Carbon Dioxide Laser Combined With PDRN Versus Fractional CO₂ Laser

Study acronym: PDRN CO2 LASER
Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated March 16, 2026 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Facial scars are frequently deemed unpleasant and can profoundly impact a patient's psychological health. This study compares the effectiveness, safety, and capacity to speed up scar healing in the maxillofacial region between fractional carbon dioxide (CO₂) laser therapy alone and polydeoxyribonucleotide (PDRN) combined with CO₂ laser therapy.
Trial Details
NCT Number NCT07472192
Lead Sponsor Misr University for Science and Technology
Conditions Facial Scarring
Enrollment 36 participants
Start Date 2026-03-01
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-16